Next Generation Surgical Robotic Platform To Be Tested
Titan Medical Inc. announced today that it has signed a non-binding memorandum of understanding (MOU) with Children's Hospital Boston. Under the terms of the agreement, Children's Hospital Boston will test and evaluate the company's Amadeus Composer. Children's Hospital Boston will provide the Company with detailed feedback as appropriate.
Dr. Reiza Rayman, President of Titan Medical Inc., commented, "We are extremely pleased to work with Children's Hospital Boston, a recognized leader in pediatric care in the U.S. This effort will validate and expand the use of our Next Generation Surgical Robotic Platform into clinical trials."
Dr. Nguyen, the Director of the Robotic Surgery, Research and Training Center, commented, "Children's Hospital Boston strives to be the leader in providing the safest and most effective care for children. Robotic technology is integral to our ability to offer innovations that improve pediatric surgical care at our institution. We are very excited to be able to participate in the evaluation of the Titan Next Generation Surgical Robotic Platform."Copyright 2011 The Associated Press.